Listen & assess
Discuss current evidence, uncertainties, alternatives, and your treatment goals.
Regenerative medicine
Exosome Therapy
Investigational cell-signaling products sometimes used alongside a broader regenerative treatment plan.
Start with the full picture
A carefully considered regenerative option
Exosomes are signaling particles released by cells; they are not stem cells. In regenerative settings they may be used to support cellular communication and tissue-repair pathways, often alongside PRP or prolotherapy.
Joint-health goalsSoft-tissue recoveryPerformance recoveryRegenerative planningAdjunct support with PRPAdjunct support with prolotherapy
Important: Exosome therapies are investigational and are not FDA-approved for the treatment of diseases or medical conditions.
What to expect
A clear path, one step at a time.
Plan with purpose
Evaluate sourcing, suitability, risks, and whether the therapy belongs in your plan.
Follow through
Use only with informed consent and provider-guided follow-up.
Questions, answered
Good to know.
Are exosomes stem cells?
No. Exosomes are signaling particles released by cells. They are not living cells and do not replicate or become other tissue types.
Is exosome therapy FDA-approved?
No exosome products are currently FDA-approved for treating diseases or conditions. These therapies are investigational.
Why are they used with PRP or prolotherapy?
Some regenerative practices use exosome products as an adjunct intended to support cell-signaling pathways, but evidence and regulation continue to evolve.
Now accepting new patients
Ready to talk about exosomes?
Book a full consultation or use the free 15-minute call to decide whether this is the right starting point.